The biennial International Conference on Malignant Lymphoma is one of the most anticipated medical meetings for our NHL and CLL study areas, including major updates for both late- and early-stage development. The breadth of content and depth of discussion at this specialized conference builds upon and complements ASCO and EHA – in many cases offering unique looks at landscape-altering clinical data.

Drawing on expertise honed year-round by our dedicated disease area specialists, ONCrg prepares detailed agendas identifying high-impact presentations. During and immediately after the conference, our team of experts sifts through the presentations, paying close attention to details while also placing them into the context of the clinical landscape at large. Thereby, ONCrg’s unique conference reports provide clients with clear, digestible top-line trends backed by granular developments. Clients also have access to our analysts post-conference to gather additional commentary and Q&A to guide strategic decision making. Ask our Conference Lead Analyst about ONCrg Conference coverage.